Skip to main content

Table 1 Summary of patient characteristics and coagulation tests by the severity of TBI

From: Prognostic value of coagulation tests for in-hospital mortality in patients with traumatic brain injury

Ā 

Severe injury (GCS 3ā€“8)

Moderate injury (GCS 9ā€“12)

Mild injury (GCS 13ā€“15)

Total

N

662

547

1110

2319

Age (yrs) (meanā€‰Ā±ā€‰SD)

47.84ā€‰Ā±ā€‰16.03

48.07ā€‰Ā±ā€‰15.95

47.05ā€‰Ā±ā€‰17.03

47.52ā€‰Ā±ā€‰16.50

Sex

ā€ƒMale

513 (77.5)

430 (78.6)

819 (73.8)

1762 (76.0)

ā€ƒFemale

149 (22.5)

117 (21.4)

291 (26.2)

557 (24.0)

Mechanism of injury

ā€ƒMotor vehicle accident

422 (63.7)

334 (61.1)

593 (53.4)

1349 (58.2)

ā€ƒFall

99 (15.0)

78 (14.3)

147 (13.2)

324 (14.0)

ā€ƒStumble

86 (13.0)

83 (15.2)

219 (19.7)

388 (16.7)

ā€ƒBlow to head

32 (4.8)

29 (5.3)

113 (10.2)

174 (7.5)

ā€ƒOthers

23 (3.5)

23 (4.2)

38 (3.4)

84 (3.6)

Pupillary reactions*

ā€ƒBoth reacting

387 (58.5)

528 (96.5)

1110 (100)

2025 (87.3)

ā€ƒOne reacting

195 (29.5)

19 (3.5)

0 (0)

214 (9.2)

ā€ƒNone reacting

80 (12.1)

0 (0)

0 (0)

80 (3.4)

Type of injury

ā€ƒSDH*

263 (39.7)

154 (28.2)

231 (20.8)

648 (27.9)

ā€ƒEDH

184 (27.8)

152 (27.8)

304 (27.4)

640 (27.6)

ā€ƒIPH*

526 (79.5)

435 (79.5)

610 (55.0)

1571 (67.7)

ā€ƒtSAH*

405 (61.2)

311 (56.9)

521 (46.9)

1237 (53.3)

ā€ƒDAI*

60 (9.1)

11 (2.0)

3 (0.3)

74 (3.2)

ā€ƒSkull fracture*

88 (13.3)

110 (20.1)

265 (23.9)

463 (20.0)

INR*

1.08 (1.02-1.16)

1.05 (1.00ā€“1.12)

1.03 (0.99ā€“1.08)

1.05 (1.00ā€“1.12)

INRā€‰>ā€‰1.25*

76 (11.5)

27 (4.9)

31 (2.8)

134 (5.8)

PT(s)*

12.4 (11.8-13.4)

12.0 (11.4ā€“12.8)

11.8 (11.2ā€“12.3)

12.0 (11.3ā€“12.8)

PTā€‰>ā€‰14Ā s*

100 (15.1)

36 (6.6)

51 (4.6)

187 (8.1)

APTT(s)*

26.1 (23.5ā€“29.8)

25.0 (22.0ā€“28.8)

24.7 (22.0ā€“27.5)

25.0 (22.4ā€“28.5)

APTTā€‰>ā€‰36Ā s*

64 (9.7)

24 (4.4)

43 (3.9)

131 (5.6)

FIB(g/L)*

2.1 (1.5ā€“3.1)

2.3 (1.8ā€“3.1)

2.5 (1.9ā€“3.1)

2.3 (1.8ā€“3.1)

FIBā€‰<ā€‰1.5Ā g/L*

174 (26.3)

82 (15.0)

98 (8.8)

354 (15.3)

D-dimer (mg/L)*

2.856 (0.840ā€“7.080)

2.101 (0.852ā€“5.174)

0.879 (0.300ā€“2.451)

1.552 (0.453ā€“4.298)

D-dimer <1Ā mg/L*

186 (28.1)

154 (28.2)

591 (53.2)

931 (40.1)

D-dimer 1ā€“5Ā mg/L

238 (36.0)

249 (45.5)

388 (35.0)

875 (37.7)

D-dimer >5Ā mg/L

238 (36.0)

144 (26.3)

131 (11.8)

513 (22.1)

PLT(Ɨ109/L)*

158 (115ā€“204)

167 (129-210)

178 (147ā€“213)

171 (134ā€“210)

PLTā€‰<ā€‰100ā€‰Ć—ā€‰109/L*

115 (17.4)

63 (11.5)

69 (6.2)

247 (10.7)

Coagulopathy*

201 (30.4)

105 (19.2)

126 (11.4)

432 (18.6)

Hb(g/L)*

125 (108ā€“141)

134 (117-146)

135 (123ā€“147)

133 (117ā€“145)

HCT(%)*

37.1(32.2-40.9)

38.8 (34.5ā€“42.1)

39.5 (36.3ā€“42.7)

38.7 (34.6ā€“42.1)

Glucose(mmol/L)*

8.6 (7.3ā€“10.4)

7.7 (6.7ā€“9.2)

6.8 (6.0ā€“8.0)

7.5 (6.4ā€“9.0)

ICP monitoring*

447 (67.5)

233 (42.6)

80 (7.2)

760 (32.8)

Craniectomy*

365 (55.1)

136 (24.9)

39 (3.5)

540 (23.3)

Mortality*

131 (19.8)

27 (4.9)

16 (1.4)

174 (7.5)

LOS*

18 (11-28)

15 (10-22)

9 (6ā€“14)

13 (8ā€“20)

  1. The univariate analyses of categorical data were performed with a chi-square test. Normally distributed variables were compared using ANOVA, whereas nonnormally distributed variables were compared using the Kruskal-Wallis test
  2. *Pā€‰<ā€‰0.05